AZTA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 58 industry peers in the Life Sciences Tools & Services industry. AZTA has a great financial health rating, but its profitability evaluates not so good. AZTA is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year AZTA was profitable.
AZTA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AZTA reported negative net income in multiple years.
AZTA had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

AZTA has a Return On Assets (-2.71%) which is comparable to the rest of the industry.
AZTA's Return On Equity of -3.23% is in line compared to the rest of the industry. AZTA outperforms 58.62% of its industry peers.

		Industry Rank	Sector Rank
ROA	-2.71%
ROE	-3.23%
ROIC	N/A

ROA(3y)-3.69%

ROA(5y)10.48%

ROE(3y)-4.38%

ROE(5y)11.73%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

AZTA has a Gross Margin (45.52%) which is in line with its industry peers.
AZTA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AZTA so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	45.52%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.36%

GM growth 5Y0.54%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AZTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AZTA has more shares outstanding
Compared to 5 years ago, AZTA has less shares outstanding
Compared to 1 year ago, AZTA has an improved debt to assets ratio.

2.2 Solvency

AZTA has an Altman-Z score of 4.81. This indicates that AZTA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.81, AZTA is in the better half of the industry, outperforming 77.59% of the companies in the same industry.
The Debt to FCF ratio of AZTA is 0.04, which is an excellent value as it means it would take AZTA, only 0.04 years of fcf income to pay off all of its debts.
AZTA's Debt to FCF ratio of 0.04 is amongst the best of the industry. AZTA outperforms 93.10% of its industry peers.
AZTA has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of AZTA (0.00) is better than 75.86% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0.04
Altman-Z	4.81

ROIC/WACCN/A

WACC11.07%

2.3 Liquidity

A Current Ratio of 2.98 indicates that AZTA has no problem at all paying its short term obligations.
AZTA has a Current ratio (2.98) which is comparable to the rest of the industry.
AZTA has a Quick Ratio of 2.66. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
AZTA has a Quick ratio of 2.66. This is comparable to the rest of the industry: AZTA outperforms 55.17% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.98
Quick Ratio	2.66

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

AZTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.27%, which is quite impressive.
Measured over the past years, AZTA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.04% on average per year.
Looking at the last year, AZTA shows a decrease in Revenue. The Revenue has decreased by -9.52% in the last year.
AZTA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.86% yearly.

EPS 1Y (TTM)29.27%

EPS 3Y0.64%

EPS 5Y-16.04%

EPS Q2Q%16.67%

Revenue 1Y (TTM)-9.52%

Revenue growth 3Y2.25%

Revenue growth 5Y8.86%

Sales Q2Q%-6.39%

3.2 Future

The Earnings Per Share is expected to grow by 27.49% on average over the next years. This is a very strong growth
AZTA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.37% yearly.

EPS Next Y51.12%

EPS Next 2Y39.62%

EPS Next 3Y33.99%

EPS Next 5Y27.49%

Revenue Next Year4.59%

Revenue Next 2Y4.91%

Revenue Next 3Y5.2%

Revenue Next 5Y5.37%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 75.72 indicates a quite expensive valuation of AZTA.
AZTA's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 28.82. AZTA is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 50.10, AZTA can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, AZTA is valued a bit cheaper than the industry average as 60.34% of the companies are valued more expensively.
AZTA is valuated expensively when we compare the Price/Forward Earnings ratio to 25.95, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	75.72
Fwd PE	50.1

4.2 Price Multiples

AZTA's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AZTA indicates a somewhat cheap valuation: AZTA is cheaper than 62.07% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	48.02
EV/EBITDA	36.42

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
AZTA's earnings are expected to grow with 33.99% in the coming years. This may justify a more expensive valuation.